相似文献
1
Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.
Small. 2009 Dec;5(23):2673-7. doi: 10.1002/smll.200900621.
2
Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
Int J Nanomedicine. 2017 Dec 28;13:187-198. doi: 10.2147/IJN.S150610. eCollection 2018.
3
Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Antioxid Redox Signal. 2014 Aug 10;21(5):707-22. doi: 10.1089/ars.2012.5076. Epub 2013 Sep 28.
4
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
Int J Nanomedicine. 2019 May 15;14:3557-3569. doi: 10.2147/IJN.S198511. eCollection 2019.
5
Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer.
Biomed Pharmacother. 2024 Sep;178:117185. doi: 10.1016/j.biopha.2024.117185. Epub 2024 Jul 24.
6
Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Chemistry. 2013 Nov 11;19(46):15593-603. doi: 10.1002/chem.201302736. Epub 2013 Oct 2.
7
Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.
J Drug Target. 2011 Dec;19(10):900-14. doi: 10.3109/1061186X.2011.622404. Epub 2011 Oct 10.
8
Regulation of Ca Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail.
ACS Nano. 2019 Jan 22;13(1):274-283. doi: 10.1021/acsnano.8b05639. Epub 2018 Dec 21.
9
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
J Colloid Interface Sci. 2018 Oct 1;527:141-150. doi: 10.1016/j.jcis.2018.05.033. Epub 2018 May 15.
10
Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
Curr Drug Deliv. 2016;13(7):1176-1182. doi: 10.2174/1567201813666151231094056.
引用本文的文献
1
Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances.
Int J Pharm X. 2025 Jul 5;10:100353. doi: 10.1016/j.ijpx.2025.100353. eCollection 2025 Dec.
2
Riding the wave of innovation: nanotechnology in nucleic acid-based cancer therapy.
3 Biotech. 2025 Jul;15(7):226. doi: 10.1007/s13205-025-04397-0. Epub 2025 Jun 27.
3
Synergistic anticancer activity of resveratrol-loaded polymeric nanoparticles and sunitinib in colorectal cancer treatment.
R Soc Open Sci. 2025 Apr 23;12(4):241817. doi: 10.1098/rsos.241817. eCollection 2025 Apr.
4
Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer.
Discov Oncol. 2025 Mar 29;16(1):422. doi: 10.1007/s12672-025-02062-9.
5
Nanomolecular silencing of TSC22D4 mRNA via a DNAsome-siRNA for enhancing insulin sensitization in hepatocytes.
Iran J Basic Med Sci. 2025;28(3):385-392. doi: 10.22038/ijbms.2024.81998.17744.
6
Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7545-7557. doi: 10.1007/s00210-024-03751-y. Epub 2025 Jan 8.
7
Nanoparticle targeting strategies for traumatic brain injury.
J Neural Eng. 2024 Dec 20;21(6). doi: 10.1088/1741-2552/ad995b.
8
Controlled and Targeted Drug Delivery Using Smart Nanovectors.
Int J Drug Discov Pharm. 2023 Mar;2(1):84-90. doi: 10.53941/ijddp.0201010. Epub 2023 Mar 20.
9
Neurotoxicity of the antineoplastic drugs: "Doxorubicin" as an example.
J Mol Histol. 2024 Dec;55(6):1023-1050. doi: 10.1007/s10735-024-10247-9. Epub 2024 Oct 1.
10
Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.
Int J Mol Sci. 2024 May 20;25(10):5553. doi: 10.3390/ijms25105553.
本文引用的文献
1
Knocking down barriers: advances in siRNA delivery.
Nat Rev Drug Discov. 2009 Feb;8(2):129-38. doi: 10.1038/nrd2742.
2
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters.
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12128-33. doi: 10.1073/pnas.0805374105. Epub 2008 Aug 19.
3
Drug delivery with carbon nanotubes for in vivo cancer treatment.
Cancer Res. 2008 Aug 15;68(16):6652-60. doi: 10.1158/0008-5472.CAN-08-1468.
4
Mesoporous silica nanoparticles deliver DNA and chemicals into plants.
Nat Nanotechnol. 2007 May;2(5):295-300. doi: 10.1038/nnano.2007.108. Epub 2007 Apr 29.
5
Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging.
J Am Chem Soc. 2008 Jul 16;130(28):9006-12. doi: 10.1021/ja800086u. Epub 2008 Jun 21.
6
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
Nucleic Acids Res. 2008 Jul;36(12):4158-71. doi: 10.1093/nar/gkn342. Epub 2008 Jun 16.
7
Determination of nanoparticle vehicle unpackaging by MR imaging of a T(2) magnetic relaxation switch.
Biomaterials. 2008 Feb;29(6):724-32. doi: 10.1016/j.biomaterials.2007.10.018. Epub 2007 Nov 19.
8
Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Small. 2007 Aug;3(8):1341-6. doi: 10.1002/smll.200700005.
9
In vivo imaging of siRNA delivery and silencing in tumors.
Nat Med. 2007 Mar;13(3):372-7. doi: 10.1038/nm1486. Epub 2007 Feb 25.
10
siRNA delivery into human T cells and primary cells with carbon-nanotube transporters.
Angew Chem Int Ed Engl. 2007;46(12):2023-7. doi: 10.1002/anie.200604295.
Zotero 插件